Clinical trial Recruiting at 1 site Interventional Ages 18 to 99

Strength and dual-task training to help people with Parkinson’s improve strength and function

Official title: Effects of a Multimodal Strength and Dual-Task Program on Sarcopenia and Functional Performance in People With Parkinson's Disease and Parkinsonian Syndromes

Run by University of Valencia · NCT07907302 · Data updated 2026-11-12

This trial tests three levels of physiotherapy, including progressive resistance training with and without cognitive dual-task and instability components, to see if they improve muscle strength, body composition, and physical function in adults with Parkinson’s or related syndromes.

Quick facts

Study typeInterventional
Ages18 Years to 99 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of Valencia
Academic / other
Locations1 site (Valencia, Valencia)
StatusRecruiting
StartedJanuary 11, 2027
Main results expectedJanuary 29, 2027
Study endsDecember 31, 2031
Registry record updatedOctober 30, 2026
Trial IDNCT07907302 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with Parkinson’s disease or parkinsonian syndromes, Hoehn and Yahr stage 1-3, able to walk, and on stable medication for at least 4 weeks.

Probably not a fit

Patients with advanced disease (Hoehn and Yahr >3), significant comorbidities, or safety concerns for supervised exercise may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, parallel-group randomized trial with three arms comparing different physiotherapy interventions for sarcopenia-related outcomes in adults with Parkinson’s disease or parkinsonian syndromes. Participants are assigned to an Education Group, Progressive Resistance Training (PRT) with cognitive dual-task, or PRT with cognitive dual-task plus instability training. The study integrates nutrition education and supervised exercise, with outcomes focusing on muscle strength, body composition, physical performance, and related domains. Eligibility includes adults with PD or parkinsonism, Hoehn and Yahr 1-3, stable medication, and ability to walk. The lead sponsor is the University of Valencia, with collaboration from CLÍNICA NYR, and the trial is conducted at Clínica NYR in Valencia.

Why it matters

Potential benefit: If successful, patients may experience improved strength, balance, and functional independence, potentially reducing falls and frailty.

How similar studies have gone: Previous resistance training studies show strength and functional gains in Parkinson’s, though integration with a sarcopenia framework and dual-task training is less established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical diagnosis of Parkinson's disease or parkinsonism confirmed by a neurologist.
* Hoehn and Yahr stage 1-3.
* Age ≥18 years.
* Stable antiparkinsonian drug treatment for at least the previous 4 weeks.
* Ability to ambulate independently, with or without assistive devices.
* Ability to understand and follow basic safety instructions.

Exclusion Criteria:

* Severe or uncontrolled additional pathology.
* Other neurological diseases that interfere with the assessment.
* Recent fractures.
* Severe dyskinesias or unpredictable motor fluctuations that compromise safety.
* Any medical condition that contraindicates supervised physical exercise

Where it's running

  • Clínica NYR
    Valencia, Valencia, Spain
    Recruiting

Study contacts

  • Principal investigator: Anna Arnal Gómez, PhD — Department of Physiotherapy, University of Valencia
  • Study coordinator: Anna Arnal Gómez, PhD
  • Email: anna.arnal@uv.es
  • Phone: +34 963983853

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.